Dhouib Rabeb, Nasreen Marufa, Othman Dk Seti Maimonah Pg, Ellis Daniel, Lee Simon, Essilfie Ama-Tawiah, Hansbro Philip M, McEwan Alastair G, Kappler Ulrike
School of Chemistry and Molecular Biosciences, Australian Infectious Disease Research Centre, The University of Queensland, St Lucia, QLD, Australia.
QIMR Berghofer Medical Research Institute, Herston, QLD, Australia.
Front Microbiol. 2021 Jul 22;12:686833. doi: 10.3389/fmicb.2021.686833. eCollection 2021.
Although molybdenum-containing enzymes are well-established as having a key role in bacterial respiration, it is increasingly recognized that some may also support bacterial virulence. Here, we show that DmsABC, a putative dimethylsulfoxide (DMSO) reductase, is required for fitness of the respiratory pathogen (Hi) in different models of infection. Expression of the operon increased with decreasing oxygen availability, but despite this, a Hi2019 strain did not show any defects in anaerobic growth on chemically defined medium (CDM), and viability was also unaffected. Although Hi2019 exhibited increased biofilm formation and greater resistance to hypochlorite killing compared to the isogenic wild-type strain, its survival in contact with primary human neutrophils, in infections of cultured tissue cells, or in a mouse model of lung infection was reduced compared to Hi2019. The tissue cell infection model revealed a two-fold decrease in intracellular survival, while in the mouse model of lung infection Hi2019 was strongly attenuated and below detection levels at 48 h post-inoculation. While Hi2019 was recovered in approximately equal numbers from bronchoalveolar lavage fluid (BALF) and lung tissue, survival of Hi2019 was reduced in lung tissue compared to BALF samples, indicating that Hi2019 had reduced access to or survival in the intracellular niche. Our data clearly indicate for the first time a role for DmsABC in infection and that the conditions under which DmsABC is required in this bacterium are closely linked to interactions with the host.
尽管含钼酶在细菌呼吸中发挥关键作用已得到充分证实,但人们越来越认识到,其中一些酶可能也有助于细菌的毒力。在此,我们表明,假定的二甲基亚砜(DMSO)还原酶DmsABC是呼吸道病原体(Hi)在不同感染模型中保持健康所必需的。该操纵子的表达随氧气可用性的降低而增加,但尽管如此,Hi2019菌株在化学限定培养基(CDM)上的厌氧生长并未表现出任何缺陷,其活力也未受影响。尽管与同基因野生型菌株相比,Hi2019表现出更强的生物膜形成能力和对次氯酸盐杀伤的更强抵抗力,但其在与原代人中性粒细胞接触、培养组织细胞感染或肺部感染小鼠模型中的存活率与Hi2019相比有所降低。组织细胞感染模型显示细胞内存活率下降了两倍,而在肺部感染小鼠模型中,Hi2019在接种后48小时时被强烈减弱且低于检测水平。虽然从支气管肺泡灌洗液(BALF)和肺组织中回收的Hi2019数量大致相等,但与BALF样本相比,Hi2019在肺组织中的存活率降低,这表明Hi2019在细胞内生态位中的存活或进入能力降低。我们的数据首次明确表明DmsABC在感染中发挥作用,并且该细菌中需要DmsABC的条件与宿主相互作用密切相关。